Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Thursday, September 1, 2011

Top 10 Most Innovative Biotech Companies



Dan Limbach

Fast Company is one of my favorite magazines, and on my must-read list every month. They recently came out with their list of the Top 10 most innovative biotech companies. Some you may recognize, others maybe not.
See the list

Tuesday, August 23, 2011

DIA 2011 Editor's Take Videos Now Available




Dan Limbach


Watch 18 short videos featuring thought leaders who attended the 2011 DIA Annual Meeting in Chicago. The clips cover topics across the entire span of the pharma industry.


Watch the Videos

New Podcast - Mentoring: A Professional Advantage




Dan Limbach


In this episode, Laurie Cooke, CEO of the Healthcare Businesswomen's Association, discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.


Date Recorded: 08/12/2011
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association

Download the Podcast

Thursday, July 28, 2011

New OnDemand Webinar - FCPA and Pharma/Life Sciences: Prove Compliance, Avoid Prosecution




Dan Limbach


The prosecution of global businesses under the Foreign Corrupt Practices Act (FCPA) is on the rise, with Pharmaceutical and Life Sciences companies at the top of the DOJ's list for investigations. Recently, a Pharma and Life Sciences company agreed to pay $70 million in FCPA penalties.

Date Recorded: 06/29/2011 Sponsored by: Aravo
Speaker: William P. Barry, Partner, Richards Kibbe & Orbe LLP.

View the webinar as an OnDemand presentation

Monday, June 6, 2011

OnDemand Webinar Now Available - Galectin-3 Treatment for Heart Failure





Dan Limbach


This webinar just became available as an OnDemand archive of the May 26, 2011 event.
Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure

This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.

Complementary Webinar. Sponsored by BG Medicine.
View the webinar

Friday, May 20, 2011

Take Health Care off the Mainframe - a TED Talk





Dan Limbach



Intel is working on new ideas in health care.

Are there better ways to treat patients? Are we treating the illness rather than using technology to predict and prevent health issues before they become a bigger problem.


At TEDMED, Eric Dishman makes a bold argument: The US health care system is like computing circa 1959, tethered to big, unwieldy central systems: hospitals, doctors, nursing homes. As our aging population booms, it's imperative, he says, to create personal, networked, home-based health care for all.

View the video

Wednesday, May 4, 2011

Free Webinar: What are Galectins and how can they advance heart failure treatment?



Dan Limbach

Our next webinar will be on May 26 at 12:00pm EST.
Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure

Register Now

This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.

Sponsored by BG Medicine and brought to you by PharmaVOICE.


Thursday, April 7, 2011

PharmaVOICE 100 is in two months! Nominate now!


Robin Robinson

Who Inspires You?

Don’t miss this opportunity to contribute to the “feel good” issue of the year!
The July/August issue of PharmaVOICE features 100 of the most inspiring individuals in the life-sciences industry as determined by you, our readers. Your personal accounts detailing how these outstanding individuals in the life-sciences industry — executives, peers, colleagues, clients, partners, etc. —have inspired you make this special issue come to life.

These inspiring individuals can come from all types of companies, sectors, and walks of life. What they have in common is that they view industry trends as opportunities. They are passionate in their pursuit of excellence. They are innovative. They pioneer new paths. They are creative. They are leaders in their field. In short, they make a difference!

Use the link below to recognize the individual, or individuals, who have had a positive impact on you, your career, your company.

Link to Nominate: http://www.pharmavoice.com/100

Tuesday, April 5, 2011

Share your Corporate Social Responsibility story with us


Robin Robinson

PharmaVOICE is reaching out to those who work in the life sciences field (to both drug manufacturers and service providers to the industry) to discover what sort of Corporate Social Responsibility policies and programs are in place.

Let us know what efforts your company is making toward corporate social responsibility. Besides good will programs, the article will also address how CSR policies are created, monitored, and implemented. Beyond philanthropy, we will also focus on corporate strategy toward ethical and sustainable business practices in this article.

Here are four basic questions we are asking:

1. What was the driver behind implementing a corporate social responsibility policy?

2. Do you have a designated staff to implement the strategy and how do you make sure the message gets to all employees?

3. How do you inform the public that you are taking these steps to ensure ethical and sustainable business? Do you think it is important for the public to know?

4. What part of your CSR are you the most proud?

Thanks for your input and for reading PharmaVOICE.

Tuesday, March 1, 2011

Four Excellent Business Book Recommendations



Dan Limbach

The Proprietor of Social Media Explorer, Jason Falls, recommends these four books if you are looking for some Spring reading. You can even view his video review here.



In Jason's words...


IdeaSelling by Sam Harrison is an easy read and a nice set of ideas on how to communicate creative ideas and sell them through to clients, bosses and the like. It’s chock full of inspirational quotes and ideas that can jump start your brain. Worth a read.
Social Media Metrics by Jim Sterne is a must-read for those of you needing to focus at least some of your efforts on measurement. It does a great job of rolling through performance indicators in the social space and how to choose which ones are key to your marketing efforts.
Branding Yourself is by my buddies Kyle Lacy and Erik Deckers and takes the personal branding concept a few steps farther than other books by thinking through the off-line as well as on-line aspects. There’s a section devoted to public speaking and other non-Internet channels, even.
Finally, The Ultimate Online Customer Service Guide from Marsha Collier offers a great primer on using the web to facilitate customer service. If you’ve heard my social media strategies talks, that’s one of the six fundamental reasons your business is involved with social media. So this is an important book and one of the first to break that social media purpose down.

Monday, January 10, 2011

Social Media for Patient Recruitment




Dan Limbach


Patient Recruitment efforts are utilizing Social Media more than ever. Here are a few links to some of the best info on this topic.




A Social Approach to Social Media
Better use of Web 2.0 sites like Twitter, Facebook and PatientsLikeMe could be a boon for enrollment.
http://www.bio-itworld.com/2010/05/21/patient-recruitment.html

Social Media for Patient Recruitment Only the Beginning
According to the Pew Research Center, 57% of American adults surf the Web for health-related information. The Pew Research Center also reports 52% of Americans 18 to 64, and 75% of those 18-29, are on at least one social networking site.
http://www.healthcaretrendsnewsletter.com/2010/07/social-media-for-patient-recruitment-only-the-beginning/

Social Media and Clinical Trial Patient Recruitment
Two years ago, nobody would have grasped that there would be any kind of link between ‘Social Media’ on one hand and ‘Clinical Trial Recruitment’ on the other hand. But the landscape has changed.
http://www.clinicaltrial-portal.com/social-media-and-clinical-trial-patient-recruitment/

Clinical trial patient recruitment: why social media alone isn’t enough
The clinical tial patient recruitment world is abuzz with excitement about social media. In particular, hopes are riding high that social media can help sponsors and sites significantly speed up the recruitment of participants.
http://www.treatmenttrials.com/blog/clinical-trial-patient-recruitment-why-social-media-alone-isn-t-enough/


Check this out:
PharmaVOICE is doing a feature story on Patient Recruitment. If you are a service provider in this area, we have a special package that combines editorial participation and a print ad in our February issue, as well as a premium online company listing. A triple threat. Interested? Contact me at dlimbach@pharmavoice.com or 847-594-0157. Offer ends this week.

Friday, January 7, 2011

The Power of Touch in Social Media




Dan Limbach


This is a nice piece about making stronger, more authentic business connections using social media. While social media communication takes place through wires and semiconductors, you can still interject the feeling of a good handshake online.

"The holy grail of social media marketing is an act that replicates the psychological effects of a great handshake: familiarity, engagement and trust."

Master the Social Media handshake
This concept benefits everything from customer service, sales and marketing, and even human resources. For pharma, it can help in your patient communucations and interactions with healthcare professionals.

Learn 6 ways to bridge the emotionless divide that is most digital communications. The best part is, it doesn't cost any more to make stronger connections online.

http://bit.ly/touchsm 

source: SmartBlog on Social Media

Monday, January 3, 2011

6 reasons why webinars make great social media marketing tools




Dan Limbach


Social media is not just about Tweets and blogs and Facebook and location-based services. Social media encompasses forms of media that were in existence well before social media was ever conceived. Social media is inclusive, not exclusive. Ignore this at your own loss. Learn how webinars can be an effective component in your social media efforts.

A 2009 study by Business.com found that a whopping 67% of business leaders who rely on social media for business information seek out relevant podcasts or webinars. That stat screams opportunity, doesn’t it?


Check out part 1 of an interview with online media guru Ann Handley.

http://bit.ly/webinarstrategy